165 related articles for article (PubMed ID: 34887290)
1. Certolizumab-induced lichenoid eruption in a patient with rheumatoid arthritis.
Kunadia A; Shulman K; Sami N
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34887290
[TBL] [Abstract][Full Text] [Related]
2. Psoriasiform skin eruption in a patient receiving certolizumab-pegol for ankylosing spondylitis: Report of a case and review of the literature.
Babuna Kobaner G; Polat Ekinci A; Yilmaz Z; Copur S
Dermatol Ther; 2018 Sep; 31(5):e12693. PubMed ID: 30225952
[TBL] [Abstract][Full Text] [Related]
3. Letter: Lichenoid eruption induced by etanercept.
Barrientos N; García-Sánchez S; Domínguez JD
Dermatol Online J; 2012 Jul; 18(7):15. PubMed ID: 22863637
[TBL] [Abstract][Full Text] [Related]
4. [Lichenoid drug reaction to leflunomide].
Canonne-Courivaud D; Carpentier O; Dejobert Y; Hachulla E; Delaporte E
Ann Dermatol Venereol; 2003 Apr; 130(4):435-7. PubMed ID: 12843855
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications.
Maul JT; Guillet C; Oschmann A; Maul LV; Meier-Schiesser B; Stadler PC; French LE; Kerl K
J Eur Acad Dermatol Venereol; 2023 May; 37(5):965-975. PubMed ID: 36652271
[TBL] [Abstract][Full Text] [Related]
6. Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis.
Ghiam N; Ojong O; Vasile G; Romanelli P; Kerdel F
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423430
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.
Cohen PR; Erickson CP; Calame A
Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898398
[TBL] [Abstract][Full Text] [Related]
8. Photoallergic Drug Eruption Caused by Certolizumab Pegol.
Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Kabashima-Kubo R; Yoshioka M; Nisio D; Nakamura M
Acta Derm Venereol; 2016 Jun; 96(5):710-1. PubMed ID: 26714785
[No Abstract] [Full Text] [Related]
9. Certolizumab pegol: in rheumatoid arthritis.
Duggan ST; Keam SJ
BioDrugs; 2009; 23(6):407-17. PubMed ID: 19894782
[TBL] [Abstract][Full Text] [Related]
10. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.
Tetzlaff MT; Nagarajan P; Chon S; Huen A; Diab A; Omar P; Aung PP; Torres-Cabala CA; Mays SR; Prieto VG; Curry JL
Am J Dermatopathol; 2017 Feb; 39(2):121-129. PubMed ID: 28134729
[TBL] [Abstract][Full Text] [Related]
11. Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
Funada M; Nawata M; Nawata A; Miyamoto T; Saito K; Tanaka Y
Mod Rheumatol Case Rep; 2021 Jan; 5(1):11-15. PubMed ID: 32687015
[TBL] [Abstract][Full Text] [Related]
12. Blaschkitis under certolizumab for rheumatoid arthritis.
Couderc M; Soubrier M
Joint Bone Spine; 2014 Jul; 81(4):372-3. PubMed ID: 24439961
[No Abstract] [Full Text] [Related]
13. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.
Smolen JS; Burmester GR; Combe B; Curtis JR; Hall S; Haraoui B; van Vollenhoven R; Cioffi C; Ecoffet C; Gervitz L; Ionescu L; Peterson L; Fleischmann R
Lancet; 2016 Dec; 388(10061):2763-2774. PubMed ID: 27863807
[TBL] [Abstract][Full Text] [Related]
14. A case of lichenoid drug eruption associated with sildenafil citratus.
Antiga E; Melani L; Cardinali C; Giomi B; Caproni M; Francalanci S; Fabbri P
J Dermatol; 2005 Dec; 32(12):972-5. PubMed ID: 16471460
[TBL] [Abstract][Full Text] [Related]
15. Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis.
Sakai H; Nomura W; Sugawara M
Case Rep Dermatol; 2017; 9(3):158-163. PubMed ID: 29033821
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.
Fleischmann R; Vencovsky J; van Vollenhoven RF; Borenstein D; Box J; Coteur G; Goel N; Brezinschek HP; Innes A; Strand V
Ann Rheum Dis; 2009 Jun; 68(6):805-11. PubMed ID: 19015206
[TBL] [Abstract][Full Text] [Related]
17. Lichenoid drug eruption probably associated with rofecoxib.
Abu-Shraie NA; Alfadley AA
Ann Pharmacother; 2004 May; 38(5):795-8. PubMed ID: 15026562
[TBL] [Abstract][Full Text] [Related]
18. [Lichenoid eruption induced by gold salts. An autonomous eruption].
Alzieu PH; Amoric JC; Bureau B; Remond L; Milpied B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1994; 121(11):798-801. PubMed ID: 7631988
[TBL] [Abstract][Full Text] [Related]
19. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
[TBL] [Abstract][Full Text] [Related]
20. Cycloserine-induced lichenoid drug eruption.
Shim JH; Kim TY; Kim HO; Kim CW
Dermatology; 1995; 191(2):142-4. PubMed ID: 8520062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
